loading

Fusion Pharmaceuticals Inc Borsa (FUSN) Ultime notizie

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

pulisher
Defense World

Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Fusion Pharmaceuticals (FUSN) Jumps: Stock Rises 9% - Yahoo Movies UK

pulisher
Yahoo Movies UK

Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Shares Acquired by Avidity Partners Management LP - MarketBeat

pulisher
MarketBeat

Superstring Capital Management LP Takes $440,000 Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - MarketBeat

pulisher
MarketBeat

AstraZeneca closes $2M precision med company buy - Delaware Business Times

pulisher
Delaware Business Times

AstraZeneca Complete Fusion Acquisition - European Pharmaceutical Manufacturer

pulisher
European Pharmaceutical Manufacturer

AstraZeneca closes $2M precision med company buy - Delaware Business Times

pulisher
Delaware Business Times

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Stock Holdings Lifted by NEOS Investment Management LLC - Defense World

pulisher
Defense World

Astrazeneca completes $2.4bn acquisition of Fusion – Financial News - FinancialNews.co.uk

pulisher
FinancialNews.co.uk

AstraZeneca completes acquisition of clinical-stage cancer drug company - delawarebusinessnow.com

pulisher
delawarebusinessnow.com

AstraZeneca Completes $2.4B Deal To Buy Pharma Co. Fusion - Law360

pulisher
Law360

AstraZeneca completes acquisition of biopharma company Fusion Pharmaceuticals - Free Malaysia Today

pulisher
Free Malaysia Today

AstraZeneca completes Fusion Pharmaceuticals acquisition - Yahoo Finance

pulisher
Yahoo Finance

AstraZeneca completes acquisition of biopharma company Fusion Pharma - Yahoo Finance

pulisher
Yahoo Finance

Acquisition of Fusion completed - PharmiWeb.com

pulisher
PharmiWeb.com

AstraZeneca completes Fusion Pharmaceuticals acquisition - Pharmaceutical Technology

pulisher
Pharmaceutical Technology

Astrazeneca swallows up Canada-based Fusion Pharmaceuticals in £1.5bn move - Yahoo Finance UK

pulisher
Yahoo Finance UK

AstraZeneca completes acquisition of Fusion Pharmaceuticals - DirectorsTalk Interviews

pulisher
DirectorsTalk Interviews

AstraZeneca completes acquisition of Fusion Pharmaceuticals - DirectorsTalk Interviews

pulisher
DirectorsTalk Interviews

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of “Hold” by Analysts - Defense World

pulisher
Defense World

AstraZeneca finalizes Fusion Pharmaceuticals buyout - Investing.com ZA - Investing.com South Africa

pulisher
Investing.com South Africa

AstraZeneca concludes acquisition of Fusion Pharma - Medical Dialogues

pulisher
Medical Dialogues

AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

AstraZeneca finalizes Fusion Pharmaceuticals buyout - Investing.com India

pulisher
Investing.com India

AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com

pulisher
Investing.com

AstraZeneca completes acquisition of Fusion Pharmaceuticals - Seeking Alpha

pulisher
Seeking Alpha

AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com UK

pulisher
Investing.com UK

Acquisition of Fusion Pharmaceuticals Completed – Company Announcement - FT.com - Financial Times

pulisher
Financial Times

The FUSN Stock Puzzle: Unraveling Fusion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle

pulisher
The InvestChronicle

Fusion Pharmaceuticals Inc (FUSN) stock: A year of ups and downs – US Post News - US Post News

pulisher
US Post News

Get in on Fusion Pharmaceuticals Inc's (FUSN) buy-in window today! – Sete News - SETE News

pulisher
SETE News

Acquisition of Fusion Pharmaceuticals Completed - PR Newswire

pulisher
PR Newswire

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

pulisher
MarketBeat

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - Defense World

pulisher
Defense World

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - Defense World

pulisher
Defense World

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Longview News-Journal

pulisher
Longview News-Journal

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - MarketBeat

pulisher
MarketBeat

Ontario court approves AstraZeneca/Fusion acquisition plan (NASDAQ:AZN) - Seeking Alpha

pulisher
Seeking Alpha

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Marketscreener.com

pulisher
Marketscreener.com

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Marketscreener.com

pulisher
Marketscreener.com

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement – Company Announcement - FT.com - Financial Times

pulisher
Financial Times

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement – Company Announcement - FT.com - Financial Times

pulisher
Financial Times

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase - MarketBeat

pulisher
MarketBeat

After Plunging 14.9% in 4 Weeks, Here's Why the Trend Might Reverse for Fusion Pharmaceuticals Inc. (FUSN) - Yahoo Movies UK

pulisher
Yahoo Movies UK

Fusion Pharmaceuticals Shareholders Back Major AstraZenica Deal - TipRanks.com - TipRanks

pulisher
TipRanks

Fusion Pharmaceuticals Shareholders Back Major AstraZenica Deal - TipRanks.com - TipRanks

pulisher
TipRanks

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca - citybiz

pulisher
citybiz
$82.33
price down icon 1.40%
$25.13
price down icon 1.76%
$142.67
price down icon 2.00%
$80.36
price down icon 0.02%
$430.04
price down icon 3.35%
$243.00
price down icon 1.62%
Capitalizzazione:     |  Volume (24 ore):